Elinjec Ingredients and Usage

The active ingredient is Ferric Carboxymaltose, a stable iron-carbohydrate complex. The 500mg/10mL solution is administered as slow intravenous injection or diluted infusion.

Elinjec is clinically indicated for:

• Iron deficiency anemia when oral iron is ineffective
• Patients with chronic kidney disease
• Inflammatory bowel disease with iron deficiency
• Heavy menstrual bleeding-associated anemia

How Does Elinjec Work?

Elinjec provides efficient iron delivery through controlled release mechanisms:

1. Stable Complex: Iron tightly bound to carboxymaltose shell
2. Controlled Release: Slow iron release to transferrin in circulation
3. Reticuloendothelial Uptake: Processed by macrophages in liver and spleen
4. Hemoglobin Synthesis: Iron incorporated into new red blood cells

Elinjec Side Effects and Warnings

Common side effects include nausea, headache, hypotension, and injection site reactions. Most effects are transient and self-limiting.

Serious Considerations

1. Hypersensitivity Reactions: Risk of anaphylaxis – monitor during infusion
2. Hypophosphatemia: May cause significant phosphate depletion
3. Oxidative Stress: Potential for increased free radical formation
4. Infusion Reactions: Flushing, dizziness, and blood pressure changes
5. Laboratory Monitoring: Check iron studies and phosphate levels

Elinjec Storage Conditions

Elinjec Injection requires proper storage handling:

• Store at room temperature below 25°C
• Protect from freezing and direct light
• Use immediately after opening
• Discard if solution appears discolored or contains particles
• Keep out of reach of children